Cancer Conmmunications - Chinese Journal of Cancer

Important notice

We would like to inform you that Chinese Journal of Cancer has changed the title to Cancer Communications on 1st March 2018.

Editorial announcement regarding title change of Chinese Journal of Cancer to Cancer Communications

Chinese Journal of Cancer获评“2017中国最具国际影响力学术期刊”

CJC's SCI Impact Factor reaches 4.111 in 2016

Chinese Journal of Cancer is collecting 150 most important questions in cancer research and clinical oncology

巧用PowerPoint制作和修改医学论文图片——编辑部业务学习会整理

Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial

hristian D. Diehl, Ehab Shiban, Christoph Straube, Jens Gempt, Jan J. Wilkens, Markus Oechsner, Carmen Kessel, Claus Zimmer, Benedict Wiestler, Bernhard Meyer & Stephanie E. Combs

[ Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/9/2019 doi:10.1186/s40880-019-0416-2

Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies

Trace M. Jones, Claudia Espitia, Wei Wang, Steffan T. Nawrocki & Jennifer S. Carew

[ Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/9/2019 doi:10.1186/s40880-019-0418-0

Nuclear glycogenolysis modulates histone acetylation: a novel mechanism of epigenetic regulation in cancer

Xifeng Dong

[ Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/9/2019 doi:10.1186/s40880-019-0420-6

CD137 expression in cancer cells: regulation and significance

Christophe Glorieux & Peng Huang

[ Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/8/2019 doi:10.1186/s40880-019-0419-z

The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706)

Zhonghan Zhang, Fan Luo, Yang Zhang, Yuxiang Ma, Shaodong Hong, Yunpeng Yang, Wenfeng Fang, Yan Huang, Li Zhang & Hongyun Zhao

[ Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/7/2019 doi:10.1186/s40880-019-0414-4

Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification

Zhi-Xia Yue, Tian-Yu Xing, Chao Gao, Shu-Guang Liu, Wen Zhao, Qian Zhao, Xi-Si Wang, Mei Jin & Xiao-Li Ma

[ Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/4/2019 doi:10.1186/s40880-019-0409-1

A case of EGFR mutation-positive lung adenocarcinoma in which the T790M allele fraction was increased by repeated EGFR-TKI treatment

Hideharu Kimura, Yoshiaki Amino, Hayato Koba, Yuichi Tambo, Noriyuki Ohkura, Johsuke Hara, Takashi Sone & Kazuo Kasahara

[ Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/1/2019 doi:10.1186/s40880-019-0413-5

Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis

Wentao Zhou, Weiwei Jin, Dansong Wang, Chao Lu, Xuefeng Xu, Renchao Zhang, Tiantao Kuang, Yucheng Zhou, Wenchuan Wu, Dayong Jin, Yiping Mou & Wenhui Lou

[ Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/28/2019 doi:10.1186/s40880-019-0410-8

S-1 plus docetaxel: a safe and effective chemotherapy regimen for stage III gastric cancer

Feiyu Diao, Wei Lai & Zhonghua Chu

[ Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/26/2019 doi:10.1186/s40880-019-0408-2

Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma

Li-Ting Liu, Melvin L. K. Chua, Yungan Tao, Lin-Quan Tang & Hai-Qiang Mai

[ Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/25/2019 doi:10.1186/s40880-019-0398-0

more papers...

Gastric cancer 　

Edited by Yun Dai and Li Yan
　

This thematic series discusses the molecular classifications of gastric cancer by the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) as well as the implications in personalized therapeutic choices; discusses the evolution of gastric surgery and presents perspectives on surgical techniques in treating gastric cancer; and reviews current and emerging targeted agents as well as immunotherapies in treating gastric cancer. With these advancements in molecular characterization, surgical intervention, and targeted and immunotherapies, gastric cancer will enter a personalized medicine era in the next 5 years.

Read thematic series >　

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -　

Tumor angiogenesis 　

Edited by Francesco Pezzella
and Chao-Nan Qian　

Forming efficient vasculature network, also known as tumor angiogenesis, is a critical hallmark in tumor development. Explorations on its underlying molecular mechanisms have resulted in several novel anti-cancer drugs. However, the modest survival benefits from anti-angiogenic therapy have forced us to revisit our understanding on tumor angiogenesis. In this special issue, world-leading experts have contributed their critical thoughts to reveal alternative tumor angiogenesis approaches and potential treatment targets.

Read thematic series >　

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -　

Lung cancer　

Edited by Lin Yan and Wei Zhang 　

Lung cancer accounts for approximately 21% of worldwide cancer deaths and a staggering 1.6 million new cases are diagnosed every year. In China, lung cancer has become a particularly challenging disease because of air pollution and smoking. This thematic series discusses the proper use of targeted agents in treating lung cancer, reviews the application of biomarkers in clinical management and drug development, and analyzes the unique challenges in developing novel drugs for lung cancer in China.

Read thematic series >　